US Healthcare Spending Rose Sharply to $5.3 Trillion in 2024

Healthcare costs in the United States surged to $5.3 trillion in 2024. This marked a 7.2% increase from $4.9 trillion in 2023, according to new data released by the Centers for Medicare & Medicaid Services (CMS). Moreover, the CMS report reveals that this growth...

Aspen Pharmacare Business Sale Sparks Investor Optimism

Aspen Pharmacare faced a turbulent 2025 marked by a severe earnings downgrade and shaken investor trust. In early 2025, Aspen announced that EBITDA for the financial year would be R2 billion below prior guidance. This surprise came just weeks after the company’s...

Hospital-Acquired Infections Lack National Tracking

South Africa lacks a national database to track hospital-acquired infections (HAIs), leaving a critical gap in patient safety and infection control. Health experts warn that the absence of systematic surveillance allows preventable infections and deaths to go...

Discovery Health Claims Reversal follows member outcry

Discovery Health Medical Scheme (DHMS) has reversed its controversial decision regarding claims overpayments. The administrator will now cover the costs after sustained member outcry and mounting public pressure. This marks a significant shift in strategy. The...

European Drug Pricing Dispute Escalates Over US Deals

Global pharmaceutical companies are entering 2026 facing a high-stakes European drug pricing dispute as they seek to offset recent price concessions in the United States. Following intense pressure from President Donald Trump, who secured major drug...

Discovery Health Claims Error Triggers Outrage Over Oversight

A year-long administrative failure at Discovery Health Medical Scheme (DHMS) has sparked mounting frustration among members, as the scheme begins recovering erroneous payments from policyholders. The Discovery Health claims error, which went undetected for 12 months,...

GEMS Tariff Intervention Underway Amid Affordability Concerns

The South African government has stepped into the controversy surrounding sharp increases in contributions to the Government Employees Medical Scheme (GEMS). Public Service and Administration Minister Mzamo Buthelezi told Parliament that officials will engage with...

Medscheme Bonitas Legal Battle Over RFPs Escalates Amid Probe

A critical legal dispute is unfolding in South Africa’s private healthcare sector. Medscheme has filed an urgent application with the Johannesburg High Court to suspend or terminate several Requests for Proposals (RFPs) issued by Bonitas Medical Fund. Furthermore, the...

NHLS Cancer Test Outsourcing Hits R116m As Backlog Cleared

South Africa’s National Health Laboratory Service (NHLS) spent approximately R116 million between June and November 2025 to outsource cancer pathology tests to private providers. The emergency measure came in response to a national outcry over dangerous delays in...